HomeCompareMGROF vs EPRT

MGROF vs EPRT: Dividend Comparison 2026

MGROF yields 500.00% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGROF wins by $61399.46M in total portfolio value
10 years
MGROF
MGROF
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full MGROF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — MGROF vs EPRT

📍 MGROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGROFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGROF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGROF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGROF
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, MGROF beats the other by $37,454,030,823.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGROF + EPRT for your $10,000?

MGROF: 50%EPRT: 50%
100% EPRT50/50100% MGROF
Portfolio after 10yr
$30699.79M
Annual income
$22,031,795,678.21/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

MGROF
No analyst data
Altman Z
-3.2
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGROF buys
0
EPRT buys
0
No recent congressional trades found for MGROF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGROFEPRT
Forward yield500.00%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$61399.52M$63.4K
Annual income after 10y$44,063,578,515.70$12,840.73
Total dividends collected$59892.67M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MGROF vs EPRT ($10,000, DRIP)

YearMGROF PortfolioMGROF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$60,700$50,000.00$11,205$505.18+$49.5KMGROF
2$348,594$283,644.86$12,672$682.46+$335.9KMGROF
3$1,895,372$1,522,376.89$14,490$930.48+$1.88MMGROF
4$9,763,990$7,735,942.00$16,786$1,282.69+$9.75MMGROF
5$47,691,977$37,244,507.54$19,753$1,791.56+$47.67MMGROF
6$221,049,019$170,018,603.23$23,677$2,541.64+$221.03MMGROF
7$972,993,924$736,471,474.07$29,008$3,672.99+$972.96MMGROF
8$4,070,762,075$3,029,658,575.98$36,463$5,425.08+$4070.73MMGROF
9$16,201,818,371$11,846,102,950.68$47,238$8,221.57+$16201.77MMGROF
10$61,399,524,173$44,063,578,515.70$63,385$12,840.73+$61399.46MMGROF

MGROF vs EPRT: Complete Analysis 2026

MGROFStock

MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Full MGROF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this MGROF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGROF vs SCHDMGROF vs JEPIMGROF vs OMGROF vs KOMGROF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.